Expression patterns of folate binding proteins one and two in the developing mouse embryo

Molecular Genetics and Metabolism

Volumn 66, Issue 1, 1999, Pages 31-39

  Barber, Robert C ^a   Bennett, Gregory D ^a,b   Greer, Kimberly A ^a   Finnell, Richard H ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Folate binding protein; Folic acid; Gene expression; Neural tube defects

Indexed keywords

FOLATE BINDING PROTEIN; FOLIC ACID;

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NONHUMAN; PLACENTA; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0032813393     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2772     Document Type: Article

References (48)

1. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. Oxford: Oxford Univ Press, 1992.
2. Carter CO. Clues to the aetiology of neural tube malformations. Dev Med Child Neur 16(Suppl 32):3-15, 1974.
3. Finnell RH, Shaw GM, Greer KA, Barber RC, Piedrahita JA, Lammer EJ. Neural tube and craniofacial defects with special emphasis on folate pathway genes. Crit Rev Oral Biol Med 9:38-53, 1998.
4. Bower C, Stanley F. The role of nutritional factors in the aetiology of neural tube defects. J Paediatr Child Health 28:12-16, 1992.
5. Czeizel ARE, Dudás I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New Engl J Med 327:1832-1835, 1992.
6. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 282:1509-1511, 1981.
7. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. J Am Med Assoc 262:2847-2852, 1989.
8. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the MRC vitamin study. Lancet 338:131-137, 1991.
9. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. J Am Med Assoc 260:3141-3145, 1988.
10. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet I:339-340, 1980.
11. Anderson RGW, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: Sequestration and transport of small molecules by caveolae. Science 255:410-411, 1992.
12. Gross S, Kamen B, Fanaroff A, Caston D. Folate compartments during gestational maturation. J Pediatr 96:842-844, 1980.
13. Kamen BA, Smith AK, Anderson RGW. The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro. J Clin Invest 87:1442-1449, 1991.
14. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RGW. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602-13609, 1988.
15. Ritter TE, Fajardo O, Matsue H, Anderson RG, Lacey SW. Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake. Proc Natl Acad Sci USA 92:3824-3828, 1995.
16. Kane MA, Waxman S. Biology of disease: Role of folate binding proteins in folate metabolism. Lab Invest 60:737-746, 1989.
17. Selhub J, Emmanouel D, Stavropoulos T, Arnold R. Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies. Am J Physiol 252:F750-F756, 1987.
18. Holm J, Hansen SI, Hoier-Madsen MI, Bostad L. High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein. Biochem J 280:267-271, 1991.
19. Antony AC. Biological chemistry of folate receptors. Blood 79:2807-2820, 1992.
20. Weitman SD, Winberg AG, Coney LR, Zuawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor: Potential role in drug toxicity in folate homeostasis. Cancer Res 52:6708-6711, 1992a.
21. Weitman SD, Lark RH, Coney LR, Fort DW, Fransca V, Zurawski VR, Kamen BA. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Can Res 52:3396-3401, 1992b.
22. Birn H, Selhub J, Christensen EI. Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am J Physiol 264:C302-C310, 1993.
23. Page ST, Owen WC, Price K, Elwood PC. Expression of the human placental folate receptor transcript is regulated in human tissues: Organization and full nucleotide sequence of the gene. J Mol Biol 229:1173-1183, 1993.
24. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Can Res 51:5329-5338, 1991.
25. Elwood PC. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J Biol Chem 264:14893-14901, 1989.
26. Lacey SW, Sanders JM, Rothberg KG, Anderson RG, Kamen BA. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J Clin Invest 84:715-720, 1989.
27. Barber RC, Shaw GM, Lammer EJ, Greer KA, Biela TA, Lacey SW, Wasserman CR, Finnell RH. Lack of association between mutations in the folate receptor-α gene and spina bifida. Am J Med Genet 76:310-317, 1998.
28. Brigle KE, Westin EH, Houghton MT, Goldman ID. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. J Biol Chem 266: 17243-17249, 1991.
29. Finnell RH, Bennett GD, Karras SB, Mohl VK. Common hierarchies of susceptibility to the induction of neural tube defects by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology 38:313-320, 1988.
30. Wlodarczyk B, Bennett GD, Calvin JA, Craig JC, Finnell RH. Arsenic-induced alterations in embryonic transcription factor gene expression: Implications for abnormal neural development. Dev Genet 18:306-315, 1996.
31. Wlodarczyk B, Craig JC, Bennett GD, Calvin JA, Finnell RH. Valproic acid induced changes in gene expression during neurulation in a mouse model. Teratology 54:284-297, 1997.
32. Snell GD, Fekete E, Hummel KP. The relation of mating, ovulation and estrus smear in the house mouse to the time of day. Anat Rec 76:30-54, 1948.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
34. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 1.53-1.73, 1988.
35. Chanarin I, Deacon R, Lumb M, Perry J. Cobalamin and folate: Recent developments. J Clin Pathol 45:277-283, 1992.
36. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In The Metabolic Basis of Inherited Diseases (Scriver CR, Beaudet AL, Sly AS, Eds.). New York: McGraw-Hill, pp 3111-3128, 1989.
37. Van Allen MI, Kalousek DK, Chernoff GF, Juriloff D, Harris M, McGillivray BC, Yong S-I, Langlois S, MacLeod PM, Chitayat D, Friedman JM, Wilson D, McFadden D, Pantzar J, Ritchie S, Hall JD. Evidence for multi-site closure of the neural tube in humans. Am J Med Gen 47:723-743, 1993.
38. Steegers-Theunissen RP. Folate metabolism and neural tube defects: A review. Eur J Obstet Gynecol Rep Biol 61: 39-48, 1995.
39. Cooper BA. Folate, its metabolism and utilization. Clin Biochem 17:95-98, 1984.
40. Trembath D, Sherbondy A, VanDyke D, Finnell R, Marker S, Murray JC. Analysis of the folate pathway genes, human T and Pax 3 in a midwestern neural tube defect population. Am J Hum Genet 59(Suppl):A144, 1996.
41. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Lacey SW, Kamen BA, Richardson J, Lark RH, Finnell RH. Inactivation of the folate binding protein genes disrupts neural tube closure. Submitted for publication.
42. Finnell RH, Wlodarczyk BC, Craig JC, Piedrahita JA, Bennett GD. Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am J Med Genet 70:303-311, 1997.
43. Strelling MK. Transfer of folate to the fetus. Dev Med Child Neur 18:533-535, 1976.
44. Johnson EM, Nelson MM, Monie IW. Effects of transitory pteroylglutamic acid (PGA) deficiency on embryonic and placental development in the rat. Anat Rec 146:215-224, 1963.
45. Elwood PC, Kane MA, Portillo RM, Kolhouse JF. The isolation, characterization, and comparison of the membrane- associated and soluble folate-binding proteins from human KB cells. J Biol Chem 261:15416-15423, 1986.
46. Ratnam M, Marquardt H, Duhring JL, Freisheim JH. Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA. Biochemistry 28: 8249-8254, 1989.
47. Sadasivan E, Cedeno M, Rothenberg SP. Genomic organization of the gene and a related pseudogene for a human folate binding protein. Biochem Biophys Acta 1131:91-94, 1992.
48. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 73:2432-2443, 1994.